Sanofi-Aventis intends to double its vaccine business in the next five years with the aid of its Asian operations and partnerships, CEO Chris Viehbacher told German newspaper Frankfurter Allgemeine Zeitung. Viehbacher said Sanofi's vaccine unit will post an increase in sales of 15% to 16% if expansion plans push through.

Full Story:

Related Summaries